ADIPOQ and type 2 diabetes mellitus: We evaluated the causal effect of circulating adiponectin on type 2 diabetes, coronary artery disease, heart failure, atrial fibrillation, cerebral ischemia and intracerebral hemorrhage using multiple MR methods (Table 2).